Article info

Download PDFPDF

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
Free

Authors

  • C Cuffari aDivision of Gastroenterology, Department of Paediatrics, The Johns Hopkins Hospital, Baltimore, MD, USA, bDivision of Gastroenterology, Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • S Hunt aDivision of Gastroenterology, Department of Paediatrics, The Johns Hopkins Hospital, Baltimore, MD, USA, bDivision of Gastroenterology, Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • T Bayless aDivision of Gastroenterology, Department of Paediatrics, The Johns Hopkins Hospital, Baltimore, MD, USA, bDivision of Gastroenterology, Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  1. C Cuffari, The Johns Hopkins Hospital, Department of Pediatrics, Division of Gastroenterology, 600N, Wolfe St, Brady 308, Baltimore, MD 21287, USA.ccuffari{at}jhmi.edu
View Full Text

Citation

Cuffari C, Hunt S, Bayless T
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

Publication history

  • Accepted December 5, 2000
  • First published May 1, 2001.
Online issue publication 
May 01, 2001

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.